Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Filgotinib/prednisolone

Disseminated herpes zoster and gastrointestinal perforation: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ishiguro N, et al. Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years. Modern rheumatology / the Japan Rheumatism Association 33: 64-72, No. 1, et al. Jan 2023. Available from: URL: http://doi.org/10.1093/mr/roac020 Ishiguro N, et al. Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years. Modern rheumatology / the Japan Rheumatism Association 33: 64-72, No. 1, et al. Jan 2023. Available from: URL: http://​doi.​org/​10.​1093/​mr/​roac020
Metadaten
Titel
Filgotinib/prednisolone
Disseminated herpes zoster and gastrointestinal perforation: 3 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41856-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Prednisolone

Case report

Atezolizumab

Case report

Ascorbic-acid